A pilot study on level of blood vasoactive factors in prehypertensive and hypertensive patients

Clinical and Experimental Hypertension

Volumn 30, Issue 7, 2008, Pages 598-605

  Wang, Zuoguang ^a   Liu, Ya ^a   Liu, Jieling ^a   Wen, Jie ^a   Wen, Shaojun ^a   Wu, Zhaosu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular diseases; Hypertension; Prehypertension; Prevention; Vasoactive factors

Indexed keywords

ADRENOMEDULLIN; ANGIOTENSIN II; ARGININE; BIOLOGICAL MARKER; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN; NITRIC OXIDE SYNTHASE; VASOACTIVE AGENT; VASOPRESSIN;

ADULT; AGE DISTRIBUTION; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; SEX DIFFERENCE; VASOPRESSIN BLOOD LEVEL;

ADRENOMEDULLIN; ADULT; ANGIOTENSIN II; ARGININE VASOPRESSIN; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; ENDOTHELINS; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PILOT PROJECTS;

EID: 54049130024     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802443068     Document Type: Article

References (27)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, et al. The seventh report of te Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-2572.
2. Droyvold WB, Midthjell K, Nilsen TI, Holmen G. Change in body mass index and its impact on blood pressure: A prospective population study. Int J Obes. 2005;29:650-655.
3. Tsai P-S, Ke T-L, Huang C-J, Tsai JC, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hyperten. 2006;23:1355-1360.
4. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens. 2005;7:729-733.
5. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among U.S. adults according to the new National Committee Guidelines. Arch Intern Med. 2004;164:2126-2134.
6. Sim MK, Qui XS. Angiotensins in plasma of hypertensive rats and human. Regul Pept. 2003;111:179-182.
7. Catena C, Zingaro L, Casaccio D, Sechi LA. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med. 2000;109:556-561.
8. Cottone S, Mule G, Nardi E, Vadala A, et al. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens. 2006;19:313-318.
9. Kaibe M, Ohishi M, Ito N, Yuan M, et al. Serum interleukin-15 concentration in patients with essential hypertension. Am J Hypertens. 2005;18:1019-1025.
10. Jin X, Xia L, Wang LS, Zheng Y, et al. Differential protein expression in hypertrophic heart with and without hypertension in hypertaneously hypertensive rats. Proteomics. 2006;6:1948-1956.
11. Escobales N, Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol. 2005;3:231-246.
12. Lee JE, Kim YG, Choi YH, et al. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension. 2006;47:962-967.
13. Liu N, Chen G, Wang X, Yao X, et al. Effects of certain vasoactive peptides on pathogenesis of vascular restenosis. Chin Med Sci J. 2003;18:1-8.
14. Zhou MS, Jaimes EA, Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. J Hypertens. 2004;44:186-190.
15. Masley SC, Phillips SE, Schocken DD. Blood pressure as a predictor of cardiovascular events in the elderly: The William Hale Research Program. Hum Hypertens. 2006;20:392-397.
16. Lee JH, Hwang SY, Kim EJ, Kim MJ. Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers. Public Health Nurs. 2006;23:314-323.
17. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens. 2004;6:562-568.
18. Moriel P, Plavnik FL, Zanella MT, Bertolami MC, et al. Lipid peroxidation and antioxidants in hyperlipidemia and hypertension. Biol Res. 2000;33:105-112.
19. Margareta Eriksson K, Westborg CJ, Eliasson MC. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health. 2006;34:453-461.
20. Mule G, Cerasola G. The metabolic syndrome and its relationship to hypertensive target organ damage. J Clin Hypertens. 2006;8:195-201.
21. Celik T, Iyisoy A, Kursaklioglu H, Turhan H, et al. Impaired aortic elastic properties in young patients with prehypertension. Blood Press Monit. 2006;11:251-255.
22. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. J Hypertens. 2006;48:254-259.
23. Hirofumi T, Tomio A, Yutaka K, Yambe M, et al. The age-related increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens Res. 2004;27:465-470.
24. Greenberg J. Are blood pressure predictors of cardiovascular disease mortality different for prehypertensives than for hypertensives? Am J Hypertens. 2006;19:454-461.
25. Ulius S, Nesbitt SD, Egan BM, Weber MA, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.
26. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133-141.
27. Cohen JD. Managing hypertension: State of the science. J Clin Hypertens. 2006;8:5-11.